Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Abstracts 8
- Acute Disease 2
- Adolescent 44
- Adult 50
- Aged 39
- Aged, 80 and over 21
- Age Distribution 4
- Animals 6
- Anthrax 2
- Anti-Bacterial Agents 12
- Anti-Infective Agents 2
- Antibiotic Prophylaxis 3
- Antibodies, Viral 2
- Antiviral Agents 5
- Article 14
- Bacteremia 4
- Bacterial Infections 3
- beta-Lactamases 3
- BetacoronaVirus 7
- Carbapenems 5
- Case-Control Studies 5
- Child 31
- Child, Preschool 27
- Clinical Laboratory Techniques 4
- Cohort Studies 3
- Communicable Disease Control 9
- Communicable Diseases, Emerging 11
- Community-Acquired Infections 6
- CoronaVirus Infections 23
- CoronaVirus Infections/Diagnosis 3
- COVID-19 34
- COVID-19 Testing 3
- COVID-19 Vaccines 9
- Cross Infection 8
- Disease Outbreaks 13
- Dispatch 9
- Dronabinol 5
- Drug Resistance, Bacterial 9
- Electronic Nicotine Delivery Systems 5
- Emerging Infections Program (EIP) 4
- Enterobacteriaceae 4
- Enterobacteriaceae Infections 5
- Epidemiological Monitoring 4
- Female 57
- Follow-Up Studies 3
- Full Report 12
- Haemophilus Infections 3
- Haemophilus influenzae 4
- Health Personnel 5
- Health Surveys 3
- History, 21st Century 3
- Homes for the Aged 3
- Hospitalization 29
- Hospital Mortality 3
- Humans 103
- Incidence 15
- Infant 32
- Infant, Newborn 17
- Influenza, Human 17
- Influenza A Virus, H1N1 Subtype 6
- Influenza Vaccines 5
- Lung Injury 6
- Male 55
- Meningococcal Infections 3
- Methicillin-Resistant Staphylococcus aureus 5
- Methicillin Resistance 4
- Microbial Sensitivity Tests 4
- Middle Aged 47
- Minnesota 6
- Multilocus Sequence Typing 3
- Nursing Homes 5
- Occupational Exposure 4
- Pandemics 17
- Patient Admission 3
- Pneumonia, Viral 9
- Population Surveillance 23
- Pregnancy 6
- Prevalence 4
- Public Health 5
- Public Health Surveillance 10
- Questionnaires 4
- Research 5
- Retrospective Studies 9
- Risk Assessment 4
- Risk Factors 15
- SARS-CoV-2 14
- Seasons 5
- Serotyping 7
- Severity of Illness Index 7
- Shock, Septic 4
- Staphylococcal Infections 10
- Staphylococcus aureus 3
- Streptococcal Infections 9
- Streptococcus agalactiae 5
- Streptococcus pyogenes 3
- Treatment Outcome 4
- United States 16
- Vaccination 10
- Vaping 7
- Young Adult 37
Personal Author
- Lynfield, Ruth (137)
Corporate Author
- Alabama. Department of Health. 1
- Alaska. Department of Health and Social Services. 1
- Anthrax Investigation Team 1
- Arizona. Department of Health Services. 1
- Association of Public Health Laboratories (U.S.) 2
- Association of State and Territorial Health Officials (U.S.) 2
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia 2
- Atlanta Veterans Affairs Medical Center. Emerging Infections Program. 1
- California Emerging Infections Program 2
- California Emerging Infections Program. 4
- California Emerging Infections Program.for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. 1
- Career Epidemiology Field Officer Program 1
- CDC COVID-19 Emergency Response Team 2
- CDC COVID-19 Response Team 1
- CDC COVID-19 Response Team. 5
- CDC COVID-19 Response Team. Data Analytics and Visualization Task Force. 1
- CDC COVID-19 Response Team. Epidemiology Task Force. 1
- CDC COVID-NET Surveillance Team. 2
- CDC COVID-NET Team. 3
- CDC Zambia. 1
- Center for Global Health (U.S.). 1
- Center for Preparedness and Response (U.S.)Division of State and Local Readiness. 2
- Center for Preparedness and Response(U.S.) Division of State and Local Readiness. 1
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.) 2
- Centers for Disease Control and Prevention (U.S.) 4
- Centers for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. 1
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 7
- Centers for Disease Control and Prevention (U.S.) Epidemic Intelligence Service. 1
- Centers for Disease Control and Prevention (U.S.)Lung Injury Response Epidemiology/Surveillance Group. 1
- Centers for Disease Control and Prevention (U.S.)Lung Injury Response Epidemiology/Surveillance Task Force. 1
- Centers for Disease Control and Prevention (U.S.)Office of Minority Health and Health Equity. 1
- Centers for Disease Control and Prevention (U.S.)Office of Minority Health and Health Equity.. 1
- Centers for Disease Control and Prevention (U.S.)Office of the Director. Deputy Director for Non-Infectious Diseases. 1
- Cherokee Nation Assurance (Arlington, Virginia) 1
- Cherokee Nation Assurance. 1
- Colorado. Department of Public Health & Environment. 1
- Colorado. Department of Public Health and Environment. 5
- Colorado. Department of Public Health and Environment. Connecticut Emerging Infections Program. 1
- Colorado Department of Public Health and Environment, 1
- Colorado Dept. of Public Health and Environment 2
- Council of State and Territorial Epidemiologists (U.S.) 1
- Council of State and Territorial Epidemiologists. 2
- COVID-NET Surveillance Team 12
- COVID-NET Surveillance Team. 2
- Eagle Global Scientific (Atlanta, Georgia) 1
- Eagle Global Scientific. 1
- Emerging Infections Program Hospital Prevalence Survey Team 1
- Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators 1
- Emory University. School of Medicine. Department of Medicine. Emory University. School of Medicine. Department of Pediatrics. 1
- Emory University School of Medicine 2
- Emory University School of Medicine. 2
- Emory University School of Medicine. Departments of Medicine and Pediatrics. 1
- Emory University School of Medicine. Departments of Pediatrics and Medicine. 1
- Emory University School of Medicine. Division of Infectious Diseases. 1
- Epidemic Intelligence Service 2
- Foundation for Atlanta Veterans Education and Research. 1
- General Dynamics Information Technology 2
- General Dynamics Information Technology. 3
- Georgia Emerging Infections Program 2
- Georgia Emerging Infections Program. 3
- Hokkaido University (Research Center for Zoonosis Control) 1
- Indiana. State Department of Health. 2
- Iowa. Department of Public Health. 3
- Iowa Dept. of Health 1
- Iowa Dept. of Public Health 1
- Los Angeles County (Calif.). Department of Public Health. Acute Communicable Disease Control Program. 1
- Louisiana. Department of Health. 1
- Louisiana Department of Health. 1
- Lung Injury Response Clinical Task Force 1
- Lung Injury Response Epidemiology/Surveillance Task Force 3
- Lung Injury Response Epidemiology/Surveillance Task Force. 2
- Lung Injury Response Task Force 1
- Maine Center for Disease Control and Prevention. 1
- Maryland. Department of Health. 6
- Michigan. Department of Health and Human Services. 5
- Minnesota. Department of Health. 11
- Minnesota Dept. of Health 2
- National Center for Chronic Disease Prevention and Health Promotion (U.S.) 2
- National Center for Immunization and Respiratory Diseases (U.S.) 2
- National Center for Injury Prevention and Control (U.S.) 2
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention) 2
- New Mexico. Department of Health. 3
- New Mexico Dept. of Health 2
- New Mexico Emerging Infections Program, Albuquerque, New Mexico 2
- New York (N.Y.). Department of Health and Mental Hygiene. 2
- New York (State). Department of Health. 3
- New York State Dept. of Health 2
- North Carolina. Department of Health and Human Services. 2
- Ohio. Department of Health. 4
- Ohio Dept. of Health 2
- Oregon Health Authority. Public Health Division. 4
- Oregon Health Authority Public Health Div. 2
- Salt Lake County (Utah). Health Department. 5
- University of Rochester. School of Medicine and Dentistry. 3
- University of Rochester School of Medicine and Dentistry 2
- University of Rochester School of Medicine and Dentistry. 2
- Utah. Department of Health. 2
- Vanderbilt University Medical Center 2
- Vanderbilt University Medical Center. 4
- Yale University School of Public Health Connecticut Emerging Infections Program 2
Place as Subject
- Alabama 1
- Arizona 1
- California 5
- Colorado 6
- Connecticut 5
- Georgia 5
- Indiana 1
- Iowa 5
- Los Angeles, CA 1
- Louisiana 1
- Maryland 6
- Michigan 5
- Minnesota 25
- Minnesota, 1
- Minnestota 1
- New Mexico 7
- New York 5
- New York City, NY 2
- North Carolina 1
- Ohio 5
- Oregon 5
- OregonTennessee 1
- Seattle, WA 1
- South Dakota 2
- Tennessee 4
- U.S. 6
- United States 49
- Utah 6
- Wisconsin 2
Resource Type General
- Journal Article (137)
Resource Type Specific
Keywords
- Adolescent 2
- Adult 3
- Aged 3
- American Indian and Alaska Native 1
- Anti-Bacterial Agents 1
- Anti-Infective Agents 1
- anti-infective agents 1
- antibiotic 1
- antimicrobial resistance 1
- antimicrobial stewardship 1
- antimicrobial use 1
- Bacteremia 1
- bacteria 2
- bacterial infections 1
- bat 1
- beta-Lactamases 1
- bloodstream infections 1
- carbapenem-resistant Enterobacterales 1
- Carbapenemase-producing enterobacterales 1
- Carbapenems 1
- Child 2
- child 1
- Child, Preschool 2
- Chlorination 4
- co-infection 1
- Coinfection 1
- communicable diseases 1
- Community-Acquired Infections 3
- Community-associated disease 1
- Contact Tracing 1
- Cost of Illness 1
- COVID-19 2
- COVID-19–associated hospitalizations 1
- Cross-Sectional Studies 1
- Cross Infection 2
- Data Collection 1
- Disease Outbreaks 1
- Enterobacterales 1
- Enterobacteriaceae 1
- Enterobacteriaceae Infections 1
- epidemiology 6
- extended-spectrum β-lactamase-producing Enterobacterales 1
- Female 4
- Group A Streptococcus 1
- Haemophilus influenzae 3
- Healthcare-associated infections 1
- Healthcare personnel 1
- Health Facilities 1
- Hospitalization 2
- Hospitals 1
- hospitals 1
- Household water treatment 4
- Humans 6
- immunization coverage assessment 1
- immunization information system 1
- Incidence 1
- Infant 2
- infection control 1
- Infections 1
- influenza 2
- Influenza, Human 1
- Influenza A Virus, H3N2 Subtype 1
- Inpatients 1
- invasive bacterial disease 1
- invasive disease 2
- invasive infections 1
- Logistic Models 1
- Long-Term Care 1
- Male 3
- measles 1
- measles-mumps-rubella vaccine 1
- measles outbreak 1
- measles transmission 1
- Methicillin-Resistant Staphylococcus aureus 2
- methicillin-resistant Staphylococcus aureus 1
- Microbial Sensitivity Tests 1
- Middle Aged 3
- Monkeypox 1
- Monkeypox virus 1
- MRSA 1
- MSSA 1
- MSSA burden 1
- Multi-drug resistant gram-negative organisms 1
- Nursing home 1
- Nursing Homes 1
- parotitis 2
- Pharynx 1
- Population Surveillance 1
- post-exposure prophylaxis 2
- Practice Patterns, Physicians' 1
- Renal Dialysis 1
- Risk Factors 2
- Safe water storage 4
- SARS-CoV-2 1
- Staphylococcal Infections 2
- Streptococcal Infections 1
- Streptococcus pyogenes 1
- surveillance 3
- United States 9
- Young Adult 2
Select all docs (Max 200)
1 -
20 of 137 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Abstracts (8)
- Acute Disease (2)
- Adolescent (44)
- Adult (50)
- Aged (39)
- Aged, 80 and over (21)
- Age Distribution (4)
- Animals (6)
- Anthrax (2)
- Anti-Bacterial Agents (12)
- Anti-Infective Agents (2)
- Antibiotic Prophylaxis (3)
- Antibodies, Viral (2)
- Antiviral Agents (5)
- Article (14)
- Bacteremia (4)
- Bacterial Infections (3)
- beta-Lactamases (3)
- BetacoronaVirus (7)
- Carbapenems (5)
- Case-Control Studies (5)
- Child (31)
- Child, Preschool (27)
- Clinical Laboratory Techniques (4)
- Cohort Studies (3)
- Communicable Disease Control (9)
- Communicable Diseases, Emerging (11)
- Community-Acquired Infections (6)
- CoronaVirus Infections (23)
- CoronaVirus Infections/Diagnosis (3)
- COVID-19 (34)
- COVID-19 Testing (3)
- COVID-19 Vaccines (9)
- Cross Infection (8)
- Disease Outbreaks (13)
- Dispatch (9)
- Dronabinol (5)
- Drug Resistance, Bacterial (9)
- Electronic Nicotine Delivery Systems (5)
- Emerging Infections Program (EIP) (4)
- Enterobacteriaceae (4)
- Enterobacteriaceae Infections (5)
- Epidemiological Monitoring (4)
- Female (57)
- Follow-Up Studies (3)
- Full Report (12)
- Haemophilus Infections (3)
- Haemophilus influenzae (4)
- Health Personnel (5)
- Health Surveys (3)
- History, 21st Century (3)
- Homes for the Aged (3)
- Hospitalization (29)
- Hospital Mortality (3)
- Humans (103)
- Incidence (15)
- Infant (32)
- Infant, Newborn (17)
- Influenza, Human (17)
- Influenza A Virus, H1N1 Subtype (6)
- Influenza Vaccines (5)
- Lung Injury (6)
- Male (55)
- Meningococcal Infections (3)
- Methicillin-Resistant Staphylococcus aureus (5)
- Methicillin Resistance (4)
- Microbial Sensitivity Tests (4)
- Middle Aged (47)
- Minnesota (6)
- Multilocus Sequence Typing (3)
- Nursing Homes (5)
- Occupational Exposure (4)
- Pandemics (17)
- Patient Admission (3)
- Pneumonia, Viral (9)
- Population Surveillance (23)
- Pregnancy (6)
- Prevalence (4)
- Public Health (5)
- Public Health Surveillance (10)
- Questionnaires (4)
- Research (5)
- Retrospective Studies (9)
- Risk Assessment (4)
- Risk Factors (15)
- SARS-CoV-2 (14)
- Seasons (5)
- Serotyping (7)
- Severity of Illness Index (7)
- Shock, Septic (4)
- Staphylococcal Infections (10)
- Staphylococcus aureus (3)
- Streptococcal Infections (9)
- Streptococcus agalactiae (5)
- Streptococcus pyogenes (3)
- Treatment Outcome (4)
- United States (16)
- Vaccination (10)
- Vaping (7)
- Young Adult (37)
- Alabama. Department of Health. (1)
- Alaska. Department of Health and Social Services. (1)
- Anthrax Investigation Team (1)
- Arizona. Department of Health Services. (1)
- Association of Public Health Laboratories (U.S.) (2)
- Association of State and Territorial Health Officials (U.S.) (2)
- Atlanta Veterans Affairs Medical Center, Atlanta, Georgia (2)
- Atlanta Veterans Affairs Medical Center. Emerging Infections Program. (1)
- California Emerging Infections Program (2)
- California Emerging Infections Program. (4)
- California Emerging Infections Program.for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. (1)
- Career Epidemiology Field Officer Program (1)
- CDC COVID-19 Emergency Response Team (2)
- CDC COVID-19 Response Team (1)
- CDC COVID-19 Response Team. (5)
- CDC COVID-19 Response Team. Data Analytics and Visualization Task Force. (1)
- CDC COVID-19 Response Team. Epidemiology Task Force. (1)
- CDC COVID-NET Surveillance Team. (2)
- CDC COVID-NET Team. (3)
- CDC Zambia. (1)
- Center for Global Health (U.S.). (1)
- Center for Preparedness and Response (U.S.)Division of State and Local Readiness. (2)
- Center for Preparedness and Response(U.S.) Division of State and Local Readiness. (1)
- Center for Surveillance, Epidemiology, and Laboratory Services (U.S.) (2)
- Centers for Disease Control and Prevention (U.S.) (4)
- Centers for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program. (1)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (7)
- Centers for Disease Control and Prevention (U.S.) Epidemic Intelligence Service. (1)
- Centers for Disease Control and Prevention (U.S.)Lung Injury Response Epidemiology/Surveillance Group. (1)
- Centers for Disease Control and Prevention (U.S.)Lung Injury Response Epidemiology/Surveillance Task Force. (1)
- Centers for Disease Control and Prevention (U.S.)Office of Minority Health and Health Equity. (1)
- Centers for Disease Control and Prevention (U.S.)Office of Minority Health and Health Equity.. (1)
- Centers for Disease Control and Prevention (U.S.)Office of the Director. Deputy Director for Non-Infectious Diseases. (1)
- Cherokee Nation Assurance (Arlington, Virginia) (1)
- Cherokee Nation Assurance. (1)
- Colorado. Department of Public Health & Environment. (1)
- Colorado. Department of Public Health and Environment. (5)
- Colorado. Department of Public Health and Environment. Connecticut Emerging Infections Program. (1)
- Colorado Department of Public Health and Environment, (1)
- Colorado Dept. of Public Health and Environment (2)
- Council of State and Territorial Epidemiologists (U.S.) (1)
- Council of State and Territorial Epidemiologists. (2)
- COVID-NET Surveillance Team (12)
- COVID-NET Surveillance Team. (2)
- Eagle Global Scientific (Atlanta, Georgia) (1)
- Eagle Global Scientific. (1)
- Emerging Infections Program Hospital Prevalence Survey Team (1)
- Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators (1)
- Emory University. School of Medicine. Department of Medicine. Emory University. School of Medicine. Department of Pediatrics. (1)
- Emory University School of Medicine (2)
- Emory University School of Medicine. (2)
- Emory University School of Medicine. Departments of Medicine and Pediatrics. (1)
- Emory University School of Medicine. Departments of Pediatrics and Medicine. (1)
- Emory University School of Medicine. Division of Infectious Diseases. (1)
- Epidemic Intelligence Service (2)
- Foundation for Atlanta Veterans Education and Research. (1)
- General Dynamics Information Technology (2)
- General Dynamics Information Technology. (3)
- Georgia Emerging Infections Program (2)
- Georgia Emerging Infections Program. (3)
- Hokkaido University (Research Center for Zoonosis Control) (1)
- Indiana. State Department of Health. (2)
- Iowa. Department of Public Health. (3)
- Iowa Dept. of Health (1)
- Iowa Dept. of Public Health (1)
- Los Angeles County (Calif.). Department of Public Health. Acute Communicable Disease Control Program. (1)
- Louisiana. Department of Health. (1)
- Louisiana Department of Health. (1)
- Lung Injury Response Clinical Task Force (1)
- Lung Injury Response Epidemiology/Surveillance Task Force (3)
- Lung Injury Response Epidemiology/Surveillance Task Force. (2)
- Lung Injury Response Task Force (1)
- Maine Center for Disease Control and Prevention. (1)
- Maryland. Department of Health. (6)
- Michigan. Department of Health and Human Services. (5)
- Minnesota. Department of Health. (11)
- Minnesota Dept. of Health (2)
- National Center for Chronic Disease Prevention and Health Promotion (U.S.) (2)
- National Center for Immunization and Respiratory Diseases (U.S.) (2)
- National Center for Injury Prevention and Control (U.S.) (2)
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention) (2)
- New Mexico. Department of Health. (3)
- New Mexico Dept. of Health (2)
- New Mexico Emerging Infections Program, Albuquerque, New Mexico (2)
- New York (N.Y.). Department of Health and Mental Hygiene. (2)
- New York (State). Department of Health. (3)
- New York State Dept. of Health (2)
- North Carolina. Department of Health and Human Services. (2)
- Ohio. Department of Health. (4)
- Ohio Dept. of Health (2)
- Oregon Health Authority. Public Health Division. (4)
- Oregon Health Authority Public Health Div. (2)
- Salt Lake County (Utah). Health Department. (5)
- University of Rochester. School of Medicine and Dentistry. (3)
- University of Rochester School of Medicine and Dentistry (2)
- University of Rochester School of Medicine and Dentistry. (2)
- Utah. Department of Health. (2)
- Vanderbilt University Medical Center (2)
- Vanderbilt University Medical Center. (4)
- Yale University School of Public Health Connecticut Emerging Infections Program (2)
- Alabama (1)
- Arizona (1)
- California (5)
- Colorado (6)
- Connecticut (5)
- Georgia (5)
- Indiana (1)
- Iowa (5)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (6)
- Michigan (5)
- Minnesota (25)
- Minnesota, (1)
- Minnestota (1)
- New Mexico (7)
- New York (5)
- New York City, NY (2)
- North Carolina (1)
- Ohio (5)
- Oregon (5)
- OregonTennessee (1)
- Seattle, WA (1)
- South Dakota (2)
- Tennessee (4)
- U.S. (6)
- United States (49)
- Utah (6)
- Wisconsin (2)
- Adolescent (2)
- Adult (3)
- Aged (3)
- American Indian and Alaska Native (1)
- Anti-Bacterial Agents (1)
- Anti-Infective Agents (1)
- anti-infective agents (1)
- antibiotic (1)
- antimicrobial resistance (1)
- antimicrobial stewardship (1)
- antimicrobial use (1)
- Bacteremia (1)
- bacteria (2)
- bacterial infections (1)
- bat (1)
- beta-Lactamases (1)
- bloodstream infections (1)
- carbapenem-resistant Enterobacterales (1)
- Carbapenemase-producing enterobacterales (1)
- Carbapenems (1)
- Child (2)
- child (1)
- Child, Preschool (2)
- Chlorination (4)
- co-infection (1)
- Coinfection (1)
- communicable diseases (1)
- Community-Acquired Infections (3)
- Community-associated disease (1)
- Contact Tracing (1)
- Cost of Illness (1)
- COVID-19 (2)
- COVID-19–associated hospitalizations (1)
- Cross-Sectional Studies (1)
- Cross Infection (2)
- Data Collection (1)
- Disease Outbreaks (1)
- Enterobacterales (1)
- Enterobacteriaceae (1)
- Enterobacteriaceae Infections (1)
- epidemiology (6)
- extended-spectrum β-lactamase-producing Enterobacterales (1)
- Female (4)
- Group A Streptococcus (1)
- Haemophilus influenzae (3)
- Healthcare-associated infections (1)
- Healthcare personnel (1)
- Health Facilities (1)
- Hospitalization (2)
- Hospitals (1)
- hospitals (1)
- Household water treatment (4)
- Humans (6)
- immunization coverage assessment (1)
- immunization information system (1)
- Incidence (1)
- Infant (2)
- infection control (1)
- Infections (1)
- influenza (2)
- Influenza, Human (1)
- Influenza A Virus, H3N2 Subtype (1)
- Inpatients (1)
- invasive bacterial disease (1)
- invasive disease (2)
- invasive infections (1)
- Logistic Models (1)
- Long-Term Care (1)
- Male (3)
- measles (1)
- measles-mumps-rubella vaccine (1)
- measles outbreak (1)
- measles transmission (1)
- Methicillin-Resistant Staphylococcus aureus (2)
- methicillin-resistant Staphylococcus aureus (1)
- Microbial Sensitivity Tests (1)
- Middle Aged (3)
- Monkeypox (1)
- Monkeypox virus (1)
- MRSA (1)
- MSSA (1)
- MSSA burden (1)
- Multi-drug resistant gram-negative organisms (1)
- Nursing home (1)
- Nursing Homes (1)
- parotitis (2)
- Pharynx (1)
- Population Surveillance (1)
- post-exposure prophylaxis (2)
- Practice Patterns, Physicians' (1)
- Renal Dialysis (1)
- Risk Factors (2)
- Safe water storage (4)
- SARS-CoV-2 (1)
- Staphylococcal Infections (2)
- Streptococcal Infections (1)
- Streptococcus pyogenes (1)
- surveillance (3)
- United States (9)
- Young Adult (2)
- :Garg, Shikha ;O’Halloran, AlissaOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S1001-S1002:BackgroundThe 2018–19 influenza season was characterized by prolonged co-circulation of Influenza A H3N2 (H3) and H1N1pdm09 (H1) viruses. We used da...
- :Chow, Eric J ;Rolfes, Melissa AOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S591-S592:BackgroundInfluenza virus infection most commonly causes acute respiratory tract illness, however may also lead to non-respiratory complications inclu...
- :Doyle, Joshua ;Garg, ShikhaOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S8:BackgroundInfluenza can lead to severe outcomes among adults hospitalized with influenza, and causes substantial annual morbidity and mortality. We ev...
- :Garg, Shikha ;Beacham, LaurenOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S26:BackgroundInfluenza vaccination may reduce illness severity among those with influenza; however, data are limited. We determined whether outcomes were...
- :Arriola, Carmen S ;Kim, LindsayDecember 23 2019 | J Pediatric Infect Dis Soc. 2019;:BackgroundRespiratory syncytial virus (RSV) is a major cause of hospitalizations in young children. We estimated the burden of community-onset RSV-ass...
- :Choi, Mary J ;Worku, ShewangizawJuly 16 2018 | Open Forum Infect Dis. 2018; 5(7):BackgroundIn April 2014, a 46-year-old returning traveler from Liberia was transported by emergency medical services to a community hospital in Minnes...
- :Spaulding, Alicen B. ;Radi, DeborahJan 15 2013 | PLoS One. 2013; 8(1).:BackgroundThe 2009 H1N1 pandemic strained healthcare systems. There was a need for supportive services, rapid antiviral access, and minimization of un...
- :Gokhale, Runa Hatti ;Sapiano, MatthewOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S87:BackgroundSepsis is an important contributor to mortality among children and young adults. However, recent studies focused on hospital management and ...
- :Grass, Julian E ;Bulens, Sandra NOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S238:BackgroundPseudomonas aeruginosa is intrinsically resistant to many commonly used antimicrobials, and carbapenems are often required to treat infectio...
- :Li, Yuan ;Rivers, JoyJuly 24 2020 | Front Microbiol. 2020; 11:BackgroundStreptococcus pyogenes is a major cause of severe, invasive infections in humans. The bacterial pathogen harbors a wide array of virulence f...
- :See, Isaac ;Ansari, UzmaOctober 23 2019 | Open Forum Infect Dis. 2019; 6(Suppl 2):S246:BackgroundCarbapenemase-producing (CP-) carbapenem-resistant Enterobacteriaceae (CRE) have been almost exclusively linked to extensive healthcare expo...
- :Eure, Taniece ;LaPlace, Lisa L.May 31 2017 | Infect Control Hosp Epidemiol. 38(8):998-1001:We assessed the appropriateness of initiating antibiotics in 49 nursing home (NH) residents receiving antibiotics for urinary tract infection (UTI) us...
- :Wiringa, Ann E. ;Shutt, Kathleen A.Dec 12 2013 | PLoS One. 2013; 8(12).:BackgroundThe detection of meningococcal outbreaks relies on serogrouping and epidemiologic definitions. Advances in molecular epidemiology have impro...
- :Moore, Matthew R. ;Link-Gelles, RuthFeb 03 2015 | Lancet Infect Dis. 15(3):301-309.:BackgroundIn 2000, 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in the U.S. and resulted in dramatic reductions in invasive pneumococ...
- :Holzhauer, Stacy M. ;Agger, William A.Sep 11 2014 | Clin Infect Dis. 59(12):1750-1756.:BackgroundRates of trichinellosis have declined significantly in the United States due to improved pork production practices and public awareness of t...
- :Harris, Christine M. ;Wu, Henry M.Dec 20 2016 | Open Forum Infect Dis. 2016; 3(4).:Background.Although human immunodeficiency virus (HIV) infection is an established risk factor for several bacterial infections, the association betwe...
- :MacNeil, Jessica R. ;Bennett, NancyJanuary 12 2015 | Pediatrics. 135(2):e305-e311:BACKGROUNDThe incidence of meningococcal disease is currently at historic lows in the United States; however, incidence remains highest among infants ...
- :Fowlkes, Ashley ;Friedlander, HannahOct 04 2017 | Open Forum Infect Dis. 2017; 4(Suppl 1):S60.:BackgroundDue to marked variability in circulating influenza viruses each year, annual evaluation of the vaccine’s effectiveness against severe outc...
- :Dharan, Nila J. ;Sokolow, Leslie Z.Jun 2014 | Pediatr Infect Dis J. 2014; 33(6):e141-e150.:Background:Young children are at increased risk of severe outcomes from influenza illness, including hospitalization. We conducted a case-control stud...
- :Arriola, Carmen ;Garg, ShikhaOct 15 2017 | Clin Infect Dis. 65(8):1289-1297.:BackgroundWe investigated the effect of influenza vaccination on disease severity in adults hospitalized with laboratory-confirmed influenza during 20...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.